Immatics NV (IMTX)
10.94
+0.13
(+1.20%)
USD |
NASDAQ |
May 17, 16:00
10.94
0.00 (0.00%)
After-Hours: 20:00
Immatics Cash from Operations (Quarterly): -35.42M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -35.42M |
| December 31, 2023 | 85.99M |
| September 30, 2023 | -33.19M |
| June 30, 2023 | -7.594M |
| March 31, 2023 | -25.47M |
| December 31, 2022 | -26.95M |
| September 30, 2022 | -33.37M |
| June 30, 2022 | 45.42M |
| March 31, 2022 | 120.50M |
| Date | Value |
|---|---|
| December 31, 2021 | -30.14M |
| September 30, 2021 | -26.02M |
| June 30, 2021 | -24.04M |
| March 31, 2021 | -20.07M |
| December 31, 2020 | -22.15M |
| September 30, 2020 | -39.46M |
| June 30, 2020 | -17.91M |
| March 31, 2020 | -12.64M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-39.46M
Minimum
Sep 2020
120.50M
Maximum
Mar 2022
-6.03M
Average
-24.04M
Median
Jun 2021
Cash from Operations (Quarterly) Benchmarks
| MorphoSys AG | -- |
| Affimed NV | -27.02M |
| InflaRx NV | -16.15M |
| BioNTech SE | -344.65M |
| CureVac NV | -45.82M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -262.66M |
| Cash from Financing (Quarterly) | 189.70M |
| Free Cash Flow | -29.05M |
| Free Cash Flow Per Share (Quarterly) | -0.4284 |
| Free Cash Flow to Equity (Quarterly) | -45.38M |
| Free Cash Flow to Firm (Quarterly) | -45.38M |
| Free Cash Flow Yield | -3.02% |